Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers

Advances in genetic sequencing and other diagnostic technologies have enabled the use of precision medicine in clinical cancer care, as well as the development of novel therapies that are targeted to specific molecular drivers of cancer. Developing these new agents and making them accessible to pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyerly, H. Kim, Ren, Jun, Canetta, Renzo, Kim, Gi Hyun, Nagai, Sumimasa, Yamaguchi, Tomohiro, Hatogai, Ken, Katayama, Hiroshi, Da Rocha Dias, Silvy, McManus, Daniel, Soltys, Kathy, Yang, Zhimin, Olopade, Olufumilayo, Goodman, Nancy, Reaman, Greg, Gross, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010455/
https://www.ncbi.nlm.nih.gov/pubmed/30521412
http://dx.doi.org/10.1200/JGO.18.00092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010455/
https://www.ncbi.nlm.nih.gov/pubmed/30521412
http://dx.doi.org/10.1200/JGO.18.00092

Ejemplares similares